Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 AUD | -2.17% | 0.00% | -39.19% |
Feb. 29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
Feb. 29 | Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Radiopharmaceutical Products
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 21-09-12 | |
Antje Wegener
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gitasha Chand
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Sherin Al-Safadi
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-23 |
David Mozley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Scot Harper
CTO | Chief Tech/Sci/R&D Officer | 67 | 21-11-30 |
Vittorio Puppo
COO | Chief Operating Officer | - | 22-05-31 |
Levente Meszaros
PRN | Corporate Officer/Principal | - | 21-12-31 |
Nathan Jong
SEC | Corporate Secretary | - | - |
Thomas Tulip
PRN | Corporate Officer/Principal | 71 | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Hopper
CHM | Chairman | 68 | 21-02-10 |
Leila Alland
BRD | Director/Board Member | 61 | 22-06-05 |
Chief Executive Officer | - | 21-09-12 | |
Ian Turner
BRD | Director/Board Member | - | - |
Hester Larkin
BRD | Director/Board Member | - | 22-02-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 371,639,096 | 274,806,210 ( 73.94 %) | 0 | 73.94 % |
Company contact information
Sector
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.19% | 13.55M | |
+26.29% | 661B | |
+26.74% | 566B | |
-6.38% | 352B | |
+19.24% | 332B | |
+3.85% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-3.95% | 145B |
- Stock Market
- Equities
- RAD Stock
- Company Radiopharm Theranostics Limited